Humoral Response to SARS-CoV-2 Vaccines in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type
Mult Scler Relat Disord 2022 May 01;61(2022)103785, C Jakubecz, XS Zhang, S Woodson, A Serra, H AbboudFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.